Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05108818 · ClinicalTrials.gov registry record · Phase 4
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
A Phase 4 study of Influenza, Human, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 700
- Enrollment target
- 1
- Study location
NCT05108818 is a Phase 4 study of Influenza, Human that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 700 participants, below the 16,185-participant average among 18 other Influenza, Human trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05108818, a Phase 4 study of Influenza, Human, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in immune responses, participants with various years of birth will be enrolled. The investigators hypothesize that humans with different birth years will mount antibody and cellular responses of different specificities following seasonal influenza vaccination.
Conditions Studied
Interventions
- BIOLOGICAL Seasonal influenza vaccine
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2028-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05108818
The ClinicalTrials.gov registry entry for NCT05108818 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 16,185-participant average among 18 other Influenza, Human trials with a reported enrollment target (96% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza, Human appearing as the primary indexed condition, and to 1 intervention - of which Seasonal influenza vaccine is the first listed.
NCT05108818 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05108818 about?
NCT05108818 is a clinical study titled "Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults". Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in immune responses, participants with various years of birth will be enrolled. The investigators hypothesize ...
What is the current status of trial NCT05108818?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 700 participants. The study started on 2021-10-07. Estimated completion is 2028-03-31.
What conditions does trial NCT05108818 study?
This clinical trial studies the following conditions: Influenza, Human.
What interventions are being tested in trial NCT05108818?
The interventions under investigation include: Seasonal influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05108818?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05108818 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza, Human
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immunologic Response to FluMist vs. Flucelvax
COMPLETED · Phase 4
-
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
COMPLETED · Phase 4
-
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
RECRUITING · Phase 2
-
Flu Infection at UPHS
RECRUITING
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
ACTIVE NOT RECRUITING · Phase 2
-
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.